David Amsellem
Stock Analyst at Piper Sandler
(4.84)
# 360
Out of 4,698 analysts
931
Total ratings
60.1%
Success rate
15.6%
Average return
Main Sectors:
Stocks Rated by David Amsellem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Reiterated: Buy | $225 → $245 | $220.83 | +10.95% | 32 | Sep 3, 2026 | |
| TEVA Teva Pharmaceutical Industries | Reiterated: Buy | $44 | $36.36 | +21.01% | 72 | Aug 27, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $310 | $246.81 | +25.60% | 69 | Aug 26, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | $165 | $111.62 | +47.82% | 34 | Aug 21, 2026 | |
| AMGN Amgen | Reiterated: Buy | $427 → $457 | $437.23 | +4.52% | 51 | Aug 20, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $298 → $303 | $256.46 | +18.15% | 26 | Aug 20, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $258 | $206.68 | +24.83% | 27 | Aug 18, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $75 | $38.09 | +96.90% | 7 | Aug 17, 2026 | |
| PTHS Pelthos Therapeutics | Reiterated: Buy | $48 | $24.35 | +97.13% | 4 | Aug 14, 2026 | |
| AMPH Amphastar Pharmaceuticals | Reiterated: Hold | $21 → $20 | $23.18 | -13.72% | 41 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $44 → $43 | $23.53 | +82.75% | 46 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $8.53 | -6.21% | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $46.10 | +41.00% | 42 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 → $210 | $155.64 | +34.93% | 43 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $66.82 | +12.24% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 | $43.53 | +51.62% | 70 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $17.44 | -2.52% | 42 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $16.88 | -28.91% | 24 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $59 | $34.94 | +68.86% | 14 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $12.39 | +45.28% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.34 | +49.81% | 7 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $5 → $14 | $13.78 | +1.60% | 18 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $111 | $71.23 | +55.83% | 4 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $46 | $42.25 | +8.88% | 17 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $9 | $9.60 | n/a | 19 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $12 | $26.35 | n/a | 39 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4.14 | $9.06 | n/a | 64 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $18 | $4.26 | n/a | 9 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $12 | $1.91 | n/a | 12 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $17 | $0.75 | n/a | 29 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $0.0077 | n/a | 7 | May 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $3 | $30.21 | n/a | 5 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $175 | $0.0001 | n/a | 7 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $28.45 | n/a | 1 | Jan 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $1.20 | n/a | 10 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0003 | n/a | 1 | Nov 11, 2013 |
Biogen
Sep 3, 2026
Reiterated: Buy
Price Target: $225 → $245
Current: $220.83
Upside: +10.95%
Teva Pharmaceutical Industries
Aug 27, 2026
Reiterated: Buy
Price Target: $44
Current: $36.36
Upside: +21.01%
Jazz Pharmaceuticals
Aug 26, 2026
Reiterated: Buy
Price Target: $310
Current: $246.81
Upside: +25.60%
Corcept Therapeutics
Aug 21, 2026
Reiterated: Buy
Price Target: $165
Current: $111.62
Upside: +47.82%
Amgen
Aug 20, 2026
Reiterated: Buy
Price Target: $427 → $457
Current: $437.23
Upside: +4.52%
AbbVie
Aug 20, 2026
Reiterated: Buy
Price Target: $298 → $303
Current: $256.46
Upside: +18.15%
Axsome Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $258
Current: $206.68
Upside: +24.83%
Definium Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $75
Current: $38.09
Upside: +96.90%
Pelthos Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $48
Current: $24.35
Upside: +97.13%
Amphastar Pharmaceuticals
Aug 7, 2026
Reiterated: Hold
Price Target: $21 → $20
Current: $23.18
Upside: -13.72%
Aug 7, 2026
Reiterated: Hold
Price Target: $44 → $43
Current: $23.53
Upside: +82.75%
Aug 7, 2026
Reiterated: Hold
Price Target: $8
Current: $8.53
Upside: -6.21%
Aug 6, 2026
Reiterated: Buy
Price Target: $65
Current: $46.10
Upside: +41.00%
Jul 31, 2026
Reiterated: Buy
Price Target: $207 → $210
Current: $155.64
Upside: +34.93%
Jul 28, 2026
Rated: Buy
Price Target: $75
Current: $66.82
Upside: +12.24%
Jul 27, 2026
Reiterated: Buy
Price Target: $66
Current: $43.53
Upside: +51.62%
Jul 20, 2026
Reiterated: Buy
Price Target: $17
Current: $17.44
Upside: -2.52%
Jun 4, 2026
Maintained: Hold
Price Target: $12
Current: $16.88
Upside: -28.91%
May 22, 2026
Reiterated: Buy
Price Target: $54 → $59
Current: $34.94
Upside: +68.86%
May 15, 2026
Reiterated: Buy
Price Target: $18
Current: $12.39
Upside: +45.28%
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $5.34
Upside: +49.81%
Apr 28, 2026
Upgraded: Hold
Price Target: $5 → $14
Current: $13.78
Upside: +1.60%
Apr 23, 2026
Maintained: Buy
Price Target: $94 → $111
Current: $71.23
Upside: +55.83%
Apr 22, 2026
Reiterated: Buy
Price Target: $48 → $46
Current: $42.25
Upside: +8.88%
Mar 21, 2025
Downgraded: Hold
Price Target: $15 → $9
Current: $9.60
Upside: n/a
Nov 7, 2024
Reiterated: Hold
Price Target: $11 → $12
Current: $26.35
Upside: n/a
Oct 31, 2024
Reiterated: Sell
Price Target: $4.14
Current: $9.06
Upside: n/a
May 22, 2024
Reiterated: Buy
Price Target: $21 → $18
Current: $4.26
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $1 → $12
Current: $1.91
Upside: n/a
Aug 9, 2023
Downgraded: Sell
Price Target: $26 → $17
Current: $0.75
Upside: n/a
May 25, 2022
Maintained: Buy
Price Target: $2
Current: $0.0077
Upside: n/a
Nov 10, 2021
Reiterated: Buy
Price Target: $20 → $3
Current: $30.21
Upside: n/a
May 6, 2021
Maintained: Buy
Price Target: $6 → $175
Current: $0.0001
Upside: n/a
Jan 23, 2019
Upgraded: Hold
Price Target: n/a
Current: $28.45
Upside: n/a
Oct 12, 2017
Reiterated: Hold
Price Target: $3 → $2
Current: $1.20
Upside: n/a
Nov 11, 2013
Initiated Coverage: Buy
Price Target: $6
Current: $0.0003
Upside: n/a